Rainbow Childrens Medicare Ltd vs Vanta Bioscience Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Rainbow Childrens Medicare Ltd is ₹ 1163 as of 26 Oct 15:30 . The P/E Ratio of Rainbow Childrens Medicare Ltd changed from 35.2 on March 2023 to 42.4 on March 2026 . This represents a CAGR of 4.76% over 4 yearsThe P/E Ratio of Vanta Bioscience Ltd changed from 229.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Rainbow Childrens Medicare Ltd changed from ₹ 7412 crore on March 2023 to ₹ 11814 crore on March 2026 . This represents a CAGR of 12.36% over 4 yearsThe Market Cap of Vanta Bioscience Ltd changed from ₹ 102.89 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 482.7 crore as compare to the Mar '26 revenue of ₹ 464.97 crore. This represent the growth of 3.81% The revenue of Vanta Bioscience Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 147.36 crore as compare to the Mar '26 ebitda of ₹ 148.23 crore. This represent the decline of -0.59% The ebitda of Vanta Bioscience Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Rainbow Childrens Medicare Ltd changed from ₹ 39.73 crore to ₹ 62.54 crore over 9 quarters. This represents a CAGR of 22.34% The net profit of Vanta Bioscience Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Rainbow Childrens Medicare Ltd changed from 13.22 % on March 2022 to 14.22 % on March 2026 . This represents a CAGR of 1.47% over 5 yearsThe Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Rainbow Childrens Medicare Ltd

Rainbow Childrens Medicare Limited was originally incorporated as Rainbow Children's Medicare Private Limited' as Private Company dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana.
Subsequently, the Company converted into a Public Limited, and name of the Company was changed to Rainbow Children's Medicare Limited' via fresh Certificate Incorporated issued by the RoC on November 20, 2021. The Company is a leading chain of multi-specialty pediatric, and obstetrics & gynecology hospitals in India, operating 19 hospitals and 5 outpatient clinic centers across 6 cities, with a total bed capacity of 1,935 beds, five of which are NABH-accredited and three of which have 183 received EDGE certification.
The core specialties are Pediatrics and Obstetrics & Gynecology and emergency services.

About Vanta Bioscience Ltd

Vanta Bioscience Limited (VBS) was originally incorporated as a Private Limited Company on 29th April 2016 and was converted into a Public Limited Company with effect from 17th March 2017. VBS is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, Company provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product.
It also provides expert services for determination of health based exposure limits (e.

FAQs for the comparison of Rainbow Childrens Medicare Ltd and Vanta Bioscience Ltd

Which company has a larger market capitalization, Rainbow Childrens Medicare Ltd or Vanta Bioscience Ltd?

Market cap of Rainbow Childrens Medicare Ltd is 11,821 Cr while Market cap of Vanta Bioscience Ltd is 14 Cr

What are the key factors driving the stock performance of Rainbow Childrens Medicare Ltd and Vanta Bioscience Ltd?

The stock performance of Rainbow Childrens Medicare Ltd and Vanta Bioscience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Rainbow Childrens Medicare Ltd and Vanta Bioscience Ltd?

As of October 26, 2026, the Rainbow Childrens Medicare Ltd stock price is INR ₹1163.95. On the other hand, Vanta Bioscience Ltd stock price is INR ₹20.4.

How do dividend payouts of Rainbow Childrens Medicare Ltd and Vanta Bioscience Ltd compare?

To compare the dividend payouts of Rainbow Childrens Medicare Ltd and Vanta Bioscience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.